94 results
8-K
EX-10.3
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
beyond the termination of Tanner' s engagement, but the CervoMed shall compensate Tanner at a reasonable rate after such termination for the time actually … or concurrent employers or companies, if any, during Tanner's engagement with the CervoMed and not to bring onto the premises of the CervoMed any unpublished
8-K
EX-10.1
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
that the Executive may have obtained in connection with the Executive’s employment or engagement with any other Person.
2.2. Position; Duties … for employment or engagement any individual who (A) is employed by, or an independent contractor of, any member of the Company Group at the time
8-K
EX-10.3
52f7yh mfjadhpe
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
oafmll4
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.2
sxfme44p1rsjy5ou078
2 Feb 24
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-10.1
26ruyqj ipewte
17 Nov 23
Entry into a Material Definitive Agreement
5:03pm
8-K/A
EX-99.1
lrpiabijl pm186
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.3
jhqqb8fvph5
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
fxph3 kpq8eivd4eyi2
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-3.5
fj553rtaz2x qiojt2
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
424B3
x1m66 vmzb6yq
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
8bszelu7jci91s
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
js0jz1deyy0ovk
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
b5cu8yhzlt
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
qe5qj264y3ki5i8r
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am